A Novel Molecular Distintion of Lymphomas
Duke University is seeking a company interested in commercializing a novel and versatile method to easily characterize different lymphomas based on patterns of microRNA expression unique to each distinct lymphoma. Each year nearly 75,000 new cases of lymphoma are diagnosed in the United States leading to over 20,000 deaths. Accurate distinction among the different lymphoma types is critical since their prognosis and treatment differs tremendously. Common lymphomas can be difficult to distinguish because of overlap in appearance and expression of cell markers. A simpler method to accurately identify the different lymphoma subtypes would have a major impact on patient diagnosis and treatment.